Semi-Annual Consolidated Statement Of Comprehensive Income

Delta-Fly Pharma, Inc. - Filing #7574302

Concept 2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-1,038,299,000 JPY
-837,528,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.